GAPDHP27

Across TCGA pan-cancer cohorts, GAPDHP27 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated GAPDHP27 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher GAPDHP27 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated GAPDHP27 expression acts as an unfavorable survival marker, although some lineages such as KIRP and LUSC show a favorable association.

LUAD, HNSC, and BRCA are the cancer types where GAPDHP27 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	All	0.171	0.464	.003	70	view →
HNSC	OS	Median	II,III,IV	0.277	0.405	.004	65	view →
BRCA	DFS	Quartile	All	0.842	0.916	<.001	48	view →
CESC	OS	Tertile	IV	0.253	0.749	<.001	40	view →
KIRP	DFS	Median	III,IV	0.914	0.150	.001	39	view →
KICH	OS	Tertile	II,III,IV	0.400	1.000	.003	33	view →
LUSC	OS	Median	II,III,IV	0.823	0.641	.001	29	view →
LIHC	DFS	Median	III,IV	0.422	0.187	.004	27	view →
UVM	DFS	Quartile	II,III,IV	0.280	0.557	.011	22	view →
MESO	DFS	Quartile	All	0.287	0.439	.018	18	view →
KIRC	DFS	Quartile	IV	0.290	0.751	.021	10	view →
THYM	DFS	Tertile	II,III,IV	0.490	0.906	.011	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

GAPDHP27–LUAD (OS)

Open the LUAD breakdown →